Moderna becomes latest company to join the ABPI
Company becomes the latest member of the ABPI and galvanises the company’s UK connections
Read More
Tag: UK
UK lags behind other nations in research and development
UK only places 11th in terms of total R&D investment as a percentage of GDP
Read More
ALTURiX Acquires UK rights to desmopressin oral solution
Deal is part of mission to increase options available prescribers, patients and the NHS
Read More
UK COVID-19 cases rising among those aged 55 and older
Certain areas in the UK have been experiencing a significant increase in COVID-19 cases in recent days
Read More
COVID-19 vaccine trial participants to be offered additional doses
‘Top-up’ doses of approved vaccines to be offered to ensure clinical trialists can travel abroad
Read More
GSK’s shingles vaccine Shingrix gains UK license
Jab aimed at adults aged 50 years and older and those at increased risk
Read More
Over 600,000 COVID-19 tests genomically sequenced in the UK
The UK is estimated to contribute around 23% of all COVID-19 sequencing uploaded to GISAID
Read More
UK sees a 20% growth in the number of advanced therapy trials, report finds
Cell and Gene Therapy Catapult report also found a surge in the number of commercially sponsored trials
Read More
UK trial will evaluate safety of mixing different COVID-19 vaccines
Com-Cov study will be the first in the world to evaluate using different vaccines in a two-dose regimen
Read More
DHSC says over four million people have received first COVID-19 vaccine dose
NHS is now offering vaccines to another two priority groups in the UK
Read More
UCB acquires new campus to support UK operations
Following completion of acquisition, site will undergo refurbishment
Read More
Report shows no-deal Brexit is still a “highly uncertain environment”
The National Audit Office report states that despite the extensive preparations, there still remains a “significant amount to do before 31 October.”
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
